1. Home
  2. WYY vs MRKR Comparison

WYY vs MRKR Comparison

Compare WYY & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WYY
  • MRKR
  • Stock Information
  • Founded
  • WYY 1991
  • MRKR N/A
  • Country
  • WYY United States
  • MRKR United States
  • Employees
  • WYY N/A
  • MRKR N/A
  • Industry
  • WYY EDP Services
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WYY Technology
  • MRKR Health Care
  • Exchange
  • WYY Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • WYY 32.7M
  • MRKR 35.8M
  • IPO Year
  • WYY 1998
  • MRKR N/A
  • Fundamental
  • Price
  • WYY $3.89
  • MRKR $3.72
  • Analyst Decision
  • WYY Strong Buy
  • MRKR Strong Buy
  • Analyst Count
  • WYY 1
  • MRKR 1
  • Target Price
  • WYY $7.00
  • MRKR $19.00
  • AVG Volume (30 Days)
  • WYY 84.1K
  • MRKR 35.3K
  • Earning Date
  • WYY 11-13-2024
  • MRKR 11-22-2024
  • Dividend Yield
  • WYY N/A
  • MRKR N/A
  • EPS Growth
  • WYY N/A
  • MRKR N/A
  • EPS
  • WYY N/A
  • MRKR N/A
  • Revenue
  • WYY $124,237,872.00
  • MRKR $3,727,435.00
  • Revenue This Year
  • WYY $25.94
  • MRKR $35.94
  • Revenue Next Year
  • WYY $13.22
  • MRKR N/A
  • P/E Ratio
  • WYY N/A
  • MRKR N/A
  • Revenue Growth
  • WYY 23.44
  • MRKR N/A
  • 52 Week Low
  • WYY $1.65
  • MRKR $2.44
  • 52 Week High
  • WYY $4.55
  • MRKR $6.16
  • Technical
  • Relative Strength Index (RSI)
  • WYY 56.14
  • MRKR 48.96
  • Support Level
  • WYY $3.57
  • MRKR $3.52
  • Resistance Level
  • WYY $4.19
  • MRKR $4.40
  • Average True Range (ATR)
  • WYY 0.17
  • MRKR 0.39
  • MACD
  • WYY 0.03
  • MRKR -0.06
  • Stochastic Oscillator
  • WYY 58.35
  • MRKR 12.37

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: